Our results suggest that the new HD-tDCS application may ameliorate neuronal death in the penumbra after stroke via the regulation of the NMDA receptor NR2B subunit and further trigger the activation of the SREBP1 signaling pathway. The gene discussed is SREBF1; the disease is Stroke.